These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28979071)

  • 1. Risk versus Benefit: Who Assesses this in the Management of Patients on Ototoxic Drugs?
    Khoza-Shangase K
    J Pharm Bioallied Sci; 2017; 9(3):171-177. PubMed ID: 28979071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaco-Audiology Vigilance in the Treatment of Adult Patients with HIV/Aids: Ototoxicity Monitoring Protocol Recommendation.
    Khoza-Shangase K
    Infect Disord Drug Targets; 2020; 20(1):33-42. PubMed ID: 30324897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk versus benefit: Should not audiologists assess this in the context of occupational noise-induced hearing loss in the mining industry?
    Khoza-Shangase K; Moroe NF
    S Afr J Commun Disord; 2020 Mar; 67(2):e1-e9. PubMed ID: 32129658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ototoxicity: A review of South African studies.
    Moodley S; Storbeck C; Gama N
    S Afr Fam Pract (2004); 2021 Mar; 63(1):e1-e10. PubMed ID: 33764142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What Are the Current Audiological Practices for Ototoxicity Assessment and Management in the South African Healthcare Context?
    Khoza-Shangase K; Masondo N
    Int J Environ Res Public Health; 2020 Apr; 17(7):. PubMed ID: 32290287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program.
    Paken J; Govender CD; Sewram V
    BMC Womens Health; 2017 Dec; 17(1):129. PubMed ID: 29228931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Pursuit of Preventive Audiology in South Africa: Scoping the Context for Ototoxicity Assessment and Management.
    Khoza-Shangase K; Masondo N
    J Pharm Bioallied Sci; 2021; 13(1):46-60. PubMed ID: 34084048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of tele-audiology in ototoxicity monitoring: A scoping review.
    Peerbhay N; Munsamy DR; Dlamini HP; Langa F; Paken J
    J Telemed Telecare; 2024 Apr; 30(3):475-496. PubMed ID: 34989631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a pharmacotherapy induced ototoxicity programme within a service-learning approach.
    Schellack N; Wium AM; Ehlert K; van Aswegen Y; Gous A
    S Afr J Commun Disord; 2015 Jun; 62(1):E1-7. PubMed ID: 26304216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public awareness of audiology, hearing and hearing health in the Limpopo Province, South Africa.
    Joubert K; Sebothoma B; Kgare KS
    S Afr J Commun Disord; 2017 Sep; 64(1):e1-e9. PubMed ID: 29041791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current practice of ototoxicity management across the United Kingdom (UK).
    Maru D; Malky GA
    Int J Audiol; 2018 Sep; 57(sup4):S76-S88. PubMed ID: 29676584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology.
    Garinis AC; Cornell A; Allada G; Fennelly KP; Maggiore RJ; Konrad-Martin D
    Int J Audiol; 2018 Sep; 57(sup4):S19-S24. PubMed ID: 28978238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knowledge of final year medicine, pharmacy, audiology and nursing students in South Africa on drug-induced ototoxicity: A pilot study.
    Mogole O; Schellack N; Hollander C; Ramma L
    S Afr J Commun Disord; 2019 Nov; 66(1):e1-e12. PubMed ID: 31793316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of audiology direct access for medicare patients complaining of impaired hearing.
    Zapala DA; Stamper GC; Shelfer JS; Walker DA; Karatayli-Ozgursoy S; Ozgursoy OB; Hawkins DB
    J Am Acad Audiol; 2010 Jun; 21(6):365-79. PubMed ID: 20701834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Audiological monitoring for ototoxic tuberculosis, human immunodeficiency virus and cancer therapies in a developing world setting.
    Harris T; Peer S; Fagan JJ
    J Laryngol Otol; 2012 Jun; 126(6):548-51. PubMed ID: 22459550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in ototoxicity monitoring in the pediatric oncology population.
    Bass JK; Bhagat SP
    J Am Acad Audiol; 2014 Sep; 25(8):760-74; quiz 782-3. PubMed ID: 25380122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current state of ototoxicity monitoring in New Zealand.
    Steffens L; Venter K; O'Beirne GA; Kelly-Campbell R; Gibbs D; Bird P
    N Z Med J; 2014 Jul; 127(1398):84-97. PubMed ID: 25146864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shifting and transforming the practice of audiology: The inclusion of traditional healing.
    Pillay D; Serooe T
    S Afr J Commun Disord; 2019 Nov; 66(1):e1-e9. PubMed ID: 31793314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.